You are viewing the site in preview mode
Skip to main content
| |
Estimate
|
95% CI
|
N of events
|
N remaining at risk
|
|---|
|
Total number of events
|
n/a
|
n/a
|
3051
|
5323
|
|
Median OS (years)
|
4.496
|
(4.172- 4.862)
|
n/a
|
n/a
|
|
1-year survival rate
|
78.4%
|
(77.5% - 79.3%)
|
1648
|
5032
|
|
3-year survival rate
|
58.9%
|
(57.6% - 60.2%)
|
2643
|
2120
|
|
5-year survival rate
|
47.7%
|
(46.2% - 49.3%)
|
2951
|
885
|
|
Advanced stage ovarian cancer cohort, TTD
|
|
Total number of events
|
n/a
|
n/a
|
4951
|
58
|
|
Median TTE (years)
|
0.304
|
---*
|
n/a
|
n/a
|
|
1-year "survival" rate
|
8.3%
|
(7.6%, 9.1%)
|
4561
|
407
|
|
Advanced stage ovarian cancer cohort, TTNT
|
|
Total number of events
|
n/a
|
n/a
|
3762
|
1247
|
|
Median TTE (years)
|
0.46
|
(0.460, 0.526)
|
n/a
|
n/a
|
|
1-year "survival" rate
|
31.9%
|
(30.6%, 33.3%)
|
3152
|
1231
|
- Abbreviations: TTD Time to treatment discontinuation, TTNT Time to next treatment, CI Confidence interval, N Number, TTE Time to event, OS Overall survival
- n/a Not applicable
- *was not evaluable
